Spain's Lung Cancer Crisis: Doctors Demand National Screening Program

Early Detection is Key: Spanish Doctors Urge National Lung Cancer Screening Program Spain faces a critical challenge with lung cancer, the leading cause of cancer-related deaths in the country. The lack of a widespread national screening program is a major concern, according to leading oncologists. In a recent video interview, Dr. Pilar Garrido, head of the Medical Oncology Department at Madrid's Ramón y Cajal Hospital, stressed the urgency of implementing such a program. "Early detection can increase survival rates by up to 80%," she stated. Dr. María Dolores Lozano, co-director of the Anatomic Pathology Service at the Clínica Universidad de Navarra, added that the current situation leads to diagnosis in advanced stages, limiting treatment options. The Lung Ambition Alliance, a coalition including AstraZeneca and the Global Lung Cancer Coalition, is actively working to raise awareness and advocate for change. Their efforts highlight the potential cost savings and improved patient outcomes associated with early detection. This initiative underscores the importance of collaborative efforts to address this critical public health issue and improve the lives of those affected by lung cancer in Spain.